comparemela.com

Latest Breaking News On - ரொகீலியோ மெய்டா - Page 7 : comparemela.com

Vaccines are satanic : Bolivia battles fake news in inoculation drive | WSAU News/Talk 550 AM · 99 9 FM

Vaccines are satanic : Bolivia battles fake news in inoculation drive

Vaccines are satanic : Bolivia battles fake news in inoculation drive
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

St Catharines company Biolyse strikes COVID 19 vaccine deal with Bolivia - PLANT

On May 11, Biolyse, a St. Catharines-based manufacturer of injectable medicines, announced an agreement with the Bolivian government to produce and export COVID-19 vaccines, if permitted by the Government of Canada. Currently, there are over 317,000 confirmed cases of COVID-19 in Bolivia, a country that has a total population of 11 million people. John R. Fulton, spokesperson for Biolyse, said that the St. Catharines facility has been trying for over a two months to get the government to start the process of achieving compulsory or voluntary licensing status, and to obtain the intellectual property waiver to produce the COVID-19 vaccine. Per Fulton, this collaboration with the government of Bolivia should satisfy the requirements for licensing and acquiring of the property waiver as laid out by the Canadian Access to Medicines Regime (CAMR).

Bolivia signs deal to import J&J vaccine from Canadian company, pending patent issues

Bolivia signs deal to import J&J vaccine from Canadian company, pending patent issues Jacquelyn LeBel © supplied by Biolyse Pharma Biolyse Pharma in St. Catharines, Ont., is hoping to obtain a compulsory licence. A Canadian company hoping to contribute to the world’s vaccination efforts says it has reached a deal to provide 15 million doses of the single-dose Johnson & Johnson/Janssen COVID-19 vaccine to Bolivia, but it cannot move ahead until it is allowed to actually produce it. Biolyse Pharma, an Ontario-based manufacturer, says it already has the capacity to produce up to 20 million doses annually of an already-approved viral-vector COVID-19 vaccine, like the AstraZeneca or Johnson & Johnson vaccines, with the potential to produce 50 million doses.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.